Published in Women's Health Weekly, September 22nd, 2005
Limited sponsorship opportunities are available for pharmaceutical companies interested in preparing for the impact of the MMA early next year. The study is the latest addition to Verispan's Strategic Study Series.
The study will explore the awareness, attitudes, and intentions of both physicians and patients about the MMA. Specifically, the MMA of 2003 offers prescription coverage beginning in January 2006 for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.